Global Diagnostic Cartridge Field Diagnostic System Market
As the global economy mends, the 2021 growth of Diagnostic Cartridge Field Diagnostic System will ... Read More
As the global economy mends, the 2021 growth of Duchenne Muscular Dystrophy (DMD) Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Duchenne Muscular Dystrophy (DMD) Therapeutics market size is USD million in 2022 from USD 1300.3 million in 2021, with a change of % between 2021 and 2022. The global Duchenne Muscular Dystrophy (DMD) Therapeutics market size will reach USD 16430 million in 2028, growing at a CAGR of 43.7% over the analysis period.
The United States Duchenne Muscular Dystrophy (DMD) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Duchenne Muscular Dystrophy (DMD) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Duchenne Muscular Dystrophy (DMD) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Duchenne Muscular Dystrophy (DMD) Therapeutics players cover Sarepta Therapeutics, PTC Therapeutics, Pfizer, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Duchenne Muscular Dystrophy (DMD) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Exondys
Emflaza
Translarna
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
As the global economy mends, the 2021 growth of Diagnostic Cartridge Field Diagnostic System will ... Read More
As the global economy mends, the 2021 growth of Antibody Therapeutics and Blood Antibody Therapeu ... Read More
As the global economy mends, the 2021 growth of Ceiling Grid System will have significant change ... Read More
As the global economy mends, the 2021 growth of Fiber Optic Temperature Sensor will have signific ... Read More